Nevertheless, for HCC, especially for early HCC, current serum biomarkers and tools, such as α-fetoprotein (AFP) and imaging techniques, displayed poor diagnostic sensitivity and specificity (Sun et al., 2015). Here, AFP is linked to hepatocellular carcinoma.